| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_MYBL2_0002600 | Exon-Exon | chr20:42331130-42333998 | chr20:43702490-43705358 | 554 nt | 0.5975 |
| hsa_MYBL2_0000200 | Intergenic-Exon | chr20:42295709-42333998 | chr20:43667069-43705358 | 1720 nt | 0.6087 |
| hsa_MYBL2_0000100 | Intergenic-Exon | chr20:42295709-42345122 | chr20:43667069-43716482 | 2713 nt | 0.6015 |
| hsa_MYBL2_0000400 | Exon-Exon | chr20:42302446-42302539 | chr20:43673806-43673899 | 94 nt | 0.5426 |
| hsa_MYBL2_0000500 | Exon-Exon | chr20:42302446-42315712 | chr20:43673806-43687072 | 480 nt | 0.5729 |
| hsa_MYBL2_0000600 | Exon-Exon | chr20:42302446-42345122 | chr20:43673806-43716482 | 2478 nt | 0.5847 |
| hsa_MYBL2_0001200 | Exon-Exon | chr20:42310424-42320959 | chr20:43681784-43692319 | 549 nt | 0.5756 |
| hsa_MYBL2_0001300 | Exon-Exon | chr20:42310424-42345122 | chr20:43681784-43716482 | 2384 nt | 0.5864 |
| hsa_MYBL2_0001500 | Exon-Exon | chr20:42311434-42345122 | chr20:43682794-43716482 | 2312 nt | 0.5852 |
| hsa_MYBL2_0001700 | Exon-Exon | chr20:42315492-42320959 | chr20:43686852-43692319 | 384 nt | 0.5833 |
A study in human acute myeloid leukemia (AML) demonstrated that the circMYBL2 is crucial for FLT3-dependent leukemia progression, where it interacts with PTBP1 to increase mutant FLT3 kinase protein levels [Di Agostino et al. DOI:10.3389/fcell.2020.00389]. A study in humans demonstrated that the circMYBL2 is a circular RNA with expression restricted to venous blood samples, serving as a specific biomarker for body fluid identification [Yu et al. DOI:10.1016/j.fsigen.2025.103416].